Priority allocation of cadaver kidneys to highly presensitized transplant recipients. Collaborative Transplant Study.
Within a prospective program of priority kidney allocation to highly presensitized recipients, 100 first and second cadaver transplants were performed from April 1985 to July 1987. The patient survival rate was 93% at 1 year. Graft survival at 1 year was 71% for first transplants and 68% for second transplants. There was a statistically significant correlation of graft outcome with matching for HLA-DR (P less than 0.02) and for HLA-B and -DR (P less than 0.02). The results demonstrate that multicenter cooperation is advantageous for the transplantation of highly presensitized recipients and that acceptable success rates can be obtained.
Opelz
G
G
Institut für Immunologie der Universität, Heidelberg, Federal Republic of Germany.
D000961:Antilymphocyte Serum / Q000302:isolation & purification; D002986:Clinical Trials as Topic; D006085:Graft Survival; D006680:HLA Antigens; D006650:Histocompatibility Testing; D006801:Humans; D007114:Immunization; D016030:Kidney Transplantation; D015337:Multicenter Studies as Topic; D011446:Prospective Studies
D000961:Antilymphocyte Serum; D006680:HLA Antigens